MyFinsight
Home
Blog
About
Cash and cash
equivalents
$34,012K
(216.60%↑ Y/Y)
Grant receivables
$2,951K
(-53.05%↓ Y/Y)
Restricted cash
equivalents
$750K
(-7.86%↓ Y/Y)
Prepaid expenses and
other current assets
$586K
(-51.45%↓ Y/Y)
Total current assets
$38,299K
(101.06%↑ Y/Y)
Right-of-use assets,
operating leases
$510K
(27.82%↑ Y/Y)
Property and equipment,
net
$87K
(-50.00%↓ Y/Y)
Total assets
$38,896K
(98.23%↑ Y/Y)
Total liabilities and
stockholders' equity
$38,896K
(98.23%↑ Y/Y)
Total stockholders'
equity
$33,024K
(369.83%↑ Y/Y)
Total liabilities
$5,872K
(-53.37%↓ Y/Y)
Accumulated deficit
-$207,149K
(-8.81%↓ Y/Y)
Additional paid-in capital
$240,078K
(21.66%↑ Y/Y)
Total current
liabilities
$5,450K
(-55.92%↓ Y/Y)
Operating lease
liabilities, non-current
$422K
(84.28%↑ Y/Y)
Common stock, 0.001 par
value, 250,000,000...
$95K
(46.15%↑ Y/Y)
Accrued expenses
$3,833K
(-59.10%↓ Y/Y)
Deferred grant income,
current
$777K
(-60.80%↓ Y/Y)
Accounts payable
$673K
(-12.71%↓ Y/Y)
Operating lease
liabilities, current
$89K
(-55.05%↓ Y/Y)
Other current
liabilities
$78K
(90.24%↑ Y/Y)
Back
Back
Balance Sheet
COGNITION THERAPEUTICS INC (CGTX)
COGNITION THERAPEUTICS INC (CGTX)
source: myfinsight.com